Jessica Ferrell

Has grant

Assistant Professor

Northeast Ohio Medical University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jessica Ferrell serves as an Assistant Professor at Northeast Ohio Medical University in the United States. Her research primarily focuses on the interplay of metabolic diseases and liver functions, with recent articles addressing topics such as metabolic dysfunction-associated liver disease, circadian rhythms, and the impact of bile acids on gut health. Dr. Ferrell's work contributes to understanding novel therapeutic approaches in the context of Type 2 diabetes mellitus and related metabolic disorders.

Recent Grants

Grant: Close

Ethanol regulation of adiponectin and its signaling

Open Date: 2021-03-01

Close Date: 2023-07-01

Grant: Close

Effects of sleep deprivation and high fat diet on human CYP7A1 circadian rhythm

Open Date: 2012-07-01

Close Date: 2015-06-30

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Vahagn Ohanyan

Northeast Ohio Medical University

UNITED STATES

View details

John Chiang

Professor

Northeast Ohio Medical University

UNITED STATES

View details

Xinwen Wang

Assistant Professor

Northeast Ohio Medical University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jessica Ferrell

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

Lactobacillus sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice

Chronobiology of Cancers in the Liver and Gut

Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches

Fibroblast Growth Factor 19 Alters Bile Acids to Induce Dysbiosis in Mice With Alcohol-Induced Liver Disease

It Takes Guts: Interactions of Intestinal Stearoyl CoA Desaturase 1 and Bile Acids

Circadian rhythms and inflammatory diseases of the liver and gut

Deletion of Smooth Muscle O-GlcNAc Transferase Prevents Development of Atherosclerosis in Western Diet-Fed Hyperglycemic ApoE-/- Mice In Vivo

Tgr5 −/− mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling

Altered serotonin metabolism in Takeda G protein-coupled receptor 5 knockout mice protects against diet-induced hepatic fibrosis

Discovery of farnesoid X receptor and its role in bile acid metabolism

Bile acid receptors and signaling crosstalk in the liver, gut and brain

Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis

Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis

Bile acid receptors FXR and TGR5 signaling in fatty liver diseases an therapy

Targeting the gut microbiota for treating colitis: Is FGF19 a magic bullet?

Collaborators (3)

Vahagn Ohanyan

John Chiang

Xinwen Wang

Make your next move.